What Role Does Immunotherapy Play in Treating Breast Cancer?
Immunotherapy, which harnesses the body's immune system to fight cancer, has shown promise in treating certain subtypes of breast cancer, particularly triple-negative breast cancer (TNBC). Checkpoint inhibitors such as pembrolizumab and atezolizumab have been approved for use in TNBC patients with specific biomarkers. These drugs work by blocking proteins that inhibit the immune response, thereby enabling the immune system to attack cancer cells more effectively.
